Scenarios that move NTRA
Natera, Inc. - Common Stock
Scenarios that move NTRA: 4 analyses, 3 positive, 1 negative.
- · OPKO Health to sell BioReference assets to Labcorp for $722M — ▼ · impact -20 · confidence low · horizon quarters
- · FDA expands ImmunityBio's Anktiva label for bladder cancer — ▲ · impact +18 · confidence low · horizon quarters
- · Mirum's Livmarli meets Phase III goal in ultra-rare liver diseases — ▲ · impact +25 · confidence low · horizon weeks
- · AstraZeneca's Etcamah fails late-stage study in first-line breast cancer — ▲ · impact +20 · confidence low · horizon quarters